Recon: Philips to cut 4,000 jobs worldwide amid slipping sales, legal action; Sumitovant Pharma purchases Myovant for $2.9B
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy